Stearoyl-CoA desaturase 1 (SCD1), the enzyme that produces these fatty acids, is highly expressed in many cancers, including breast, prostate, renal, lung, and ovarian cancer, making SCD1 an attractive target for cancer therapy (17, 18). Here, SCD is linked to ovarian carcinoma.